Press Releases - Emmaus Medical, Inc.

Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business UpdateNovember 14, 2022

Emmaus Life Sciences, Inc. today reported on its results of operations and financial condition as of and for the three and nine months ended September 30, 2022 and provided a business update

Emmaus Life Sciences Announces Collaboration with Kier (Junior) Spates to Share Personal Experience with Sickle Cell Disease and EndariSeptember 28, 2022

Emmaus Life Sciences, Inc. today announced a collaboration with the Steve Harvey Morning Show cast member Kier (Junior) Spates to share Mr. Spate’s personal experience with the use of Endari, Emmaus’ prescription L-glutamine oral powder, to treat his sickle cell disease, or SCD.

Emmaus Life Sciences Reports Q2 2022 Financial Results and Provides Business UpdateAugust 15, 2022

Emmaus Life Sciences, Inc. (OTCQX: EMMA), today reported financial results for the three and six months ended June 30, 2022 and provided a business update.

Life Sciences Investor Forum: Company Executives Present Live June 23rdJune 21, 2022

Life Sciences Investor Forum: Company Executives Present Live June 23rd

Emmaus Life Sciences Reports Q1 2022 Financial Results and Provides Business UpdateMay 13, 2022

Emmaus Life Sciences, Inc. (OTCQX: EMMA) today reported financial results for the three months ended March 31, 2022 and provided a business update.